GENFIT Announces Publication of Positive Results from the Phase 2 Clinical Trial Evaluating Elafibranor in Patients with PBC in the Journal of Hepatology
Lille, France; Cambridge, MA; February 09, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…